Group B Streptococcal Infections in Elderly Adults
Section of Infectious Disease, Departments of 1Pediatrics and 2Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas
Elderly adults account for >40% of persons with invasive group B streptococcal (GBS) disease and for >50% of GBS‐associated deaths in the United States. The prevalence of colonization among healthy elderly adults (
25%) is similar to that among women of childbearing age. Delineating contributions of comorbid conditions, altered integrity of anatomical barriers, and abnormalities in immune responses caused by immune senescence to pathogenesis require further investigation. Delayed clinical recognition of illness may contribute to poor outcome. Skin and soft‐tissue infections and bacteremia with no identified focus are common manifestations of infection in elderly adults and younger nonpregnant adults. Urinary tract infection and pneumonia are presentations more often encountered in elderly persons than in younger adults. The safety and immunogenicity of GBS serotype V–tetanus toxoid conjugate vaccine in healthy elderly persons suggest the potential for vaccination as an approach to prevention of invasive GBS infections in elderly persons.
Received 4 May 2005; accepted 30 May 2005; electronically published 16 August 2005.
Cited by
Online publication date: 15-Aug-2009.
Online publication date: 1-Jul-2009.
Online publication date: 1-Apr-2009.
CrossRef
Online publication date: 1-Jan-2009.
CrossRef
Online publication date: 1-Oct-2008.
CrossRef
Online publication date: 1-Jun-2008.
CrossRef
Online publication date: 12-Feb-2008.
CrossRef
CrossRef
Online publication date: 1-Jan-2007.
CrossRef



